Chronic constipation is a debilitating condition affecting a large portion of the Italian population, often associated with Irritable Bowel Syndrome (IBS-C). According to the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), proper management of intestinal transit is essential to prevent the onset of painful anorectal disorders.
Management of Chronic Constipation and Complications
Suffering from chronic constipation means being exposed to significant mechanical complications. Excessive straining and the presence of hard stools can cause or worsen inflammation of the hemorrhoidal plexuses, leading to bleeding hemorrhoids. Likewise, the traumatic passage of poorly hydrated stools can lead to lesions of the mucosa, such as anal fissures or anorectal fistulas, which often require specialist treatments and prolong patient discomfort. Moreover, in patients with IBS, chronic constipation profoundly alters the microbiota, creating a micro-environment favorable to pathogens.
Aleman: Natural Effectiveness and Dual Non-Irritating Action
Unlike common stimulant laxatives or other more aggressive products on the market that may cause pain and inflammation of the mucosa, Aleman stands out for a formulation based on natural ingredients specifically designed to be non-irritating. While conventional treatments often act forcibly on the intestine, Aleman uses an osmotic and prebiotic synergy that fully respects the body’s physiology.
Its advanced composition offers a complete solution:
- Osmotic Action (D-Mannitol): Thanks to the properties of D-Mannitol, the product naturally draws water into the intestinal lumen, hydrating and softening the stool to facilitate its passage without trauma or irritation.
- Prebiotic Action (FOS): Fructooligosaccharides (FOS) promote the development of a beneficial micro-environment for the bacterial flora, rebalancing the microbiota and supporting the return to a natural and regular intestinal transit.
Thanks to this combination, Aleman is the ideal treatment for the most delicate individuals, including children, pregnant women, diabetic patients and individuals affected by neurological disorders (such as Parkinson’s disease or Alzheimer’s disease). Its gentleness also makes it particularly suitable for those suffering from anorectal disorders such as hemorrhoids, fistulas and fissures, where the production of soft stools is essential to avoid pain and complications.
Clinical Results: Certified Effectiveness
The therapeutic effectiveness of Aleman is supported by solid scientific evidence. The product was the subject of a prospective study conducted on 20 patients suffering from severe constipation related to neurological diseases, whose results were officially presented at the prestigious LIMPE-DISMOV ACADEMY Congress held in Turin in 2015.
The trial monitored patients over a period of 6 weeks, showing a radical transformation of intestinal function:
- Daily bowel movement frequency: An extraordinary increase of 93% was recorded.
- Dependence on laxatives: The use of rectal laxatives (enemas or suppositories) decreased by 54%.
- Quality of defecation: The sensation of excessive straining, tenesmus and incomplete evacuation was reduced by 54%.
Are you looking for a solution ready for B2B distribution or private label?
We are certified manufacturers of medical devices, food supplements and cosmetics. Aleman is ready for market launch or private labeling, with full regulatory and clinical support.
Aleman is available for international distribution in ready-to-market or private label format, with full regulatory and clinical support.
Bibliography and Official Sources
- Gruppo FarmaImpresa. Aleman: clinical study on Constipation in Parkinson’s disease, 2015
- MSD Manuals, Constipation in Adults
- MSD Manuals, Irritable Bowel Syndrome (IBS)
- MSD Manuals, Hemorrhoids
- MSD Manuals, Anorectal Fistula
- NIDDK. Irritable Bowel Syndrome (IBS) Symptoms & Causes
